Takeda: Partners and Investors
10 investors · 7 with verified email
Takeda has 10 investors on VCSift, 7 with a verified email address. Roles include Interim Head of Global Portfolio Division, President, Research & Development and Head of CNS Drug Discovery Unit. The team invests at Seed stage. Sector focus: Biotechnology, Pharmaceutical and Pharmaceuticals. Based in United States and Japan (Boston).
How to pitch Takeda
- Match the stage. Most Takeda investors on VCSift are tagged Seed. A round outside that range is usually a pass before the deck is opened.
- Lead with the sector fit. The team's tagged focus is Biotechnology, Pharmaceutical and Pharmaceuticals. Name the thesis overlap in the first two lines of the email.
- Pick the right person. Titles on the team include Interim Head of Global Portfolio Division, President, Research & Development and Head of CNS Drug Discovery Unit. Partners and principals source deals; associates screen them. Write to the person whose portfolio is closest to yours.
- Use a direct email. 7 of the 10 Takeda profiles include a verified address, which beats a website form or a cold LinkedIn message.
Takeda investors by country
Browse the investor directory
Pre-Seed investors
Seed investors
Series A investors
Series B investors
Series C investors
Series C+ investors
Growth investors
Late Stage investors
SaaS
Fintech
HealthTech
AI/ML
CleanTech
E-Commerce
Crypto/Web3
EdTech
BioTech
Cybersecurity
PropTech
InsurTech
LegalTech
MarTech
Hardware
DeepTech
Consumer
Marketplace
Investors in United States
Investors in United Kingdom
Investors in Germany
Investors in India
Investors in Singapore
Investors in Canada
Investors in France
Investors in Israel
Investors in Australia
Investors in The Netherlands
Angel investors
VC firms
Family offices
Accelerators